355 View
0 CommentNewComments enabled
In the category:
Undefined
The introduction to this discussion lists a number of questions related to preferences for term styles and hierarchy content. The file associated with this discussion is the notes view of slide #4 from a presentation given during the May 2019 OIDM meeting. There are three major questions I've associated with this slide and I'd like your help determining the answers.
Should the drug names in these terms conform to names in the substance hierarchy?
Should the "main" term, some combination of the drug name and either resistant or susceptible be hyphenated (e.g. "Cephalosporin-resistant") or not (e.g. Ampicillin resistant)?
Should existing concepts involving specific antimicrobials (e.g. penicillin) be subtypes of concepts involving their nominal antimicrobial class (e.g. beta-lactam)?